Novartis Launches Schizophrenia Treatment Fanapt in the US, Offering
Patients an Attractive Alternative to Existing Medications
From Hugin (English) - Jan 11, 2010
Basel, January 11, 2010 - Novartis announced that Fanapt
(iloperidone) tablets are now available for use across the US for the
acute treatment of schizophrenia in adults. Fanapt is a twice- daily,
oral antipsychotic, approved by the FDA in May 2009.
Powered by LSoft's LISTSERV(R) list management software